Evidence map›Paper›PMID 11029040›Full record

ArticleMolecular biology of the cell2000

Regulation of macropinocytosis by p21-activated kinase-1.

S Dharmawardhane, A Schürmann, M A Sells, J Chernoff, S L Schmid, G M Bokoch

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 299 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Cellular Regulation of Macropinocytosis.International journal of molecular sciences · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Revealing macropinocytosis using nanoparticles.Molecular aspects of medicine · 2022
    Review
  19. Article
  20. Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

S DharmawardhaneDepartment of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA.
A Schürmann
M A Sells
J Chernoff
S L Schmid
G M Bokoch
Scripps Research Institute · USFox Chase Cancer Center · US

Funding

VESICULAR TRAFFICKING OF THE EGF RECEPTORP01CA058689 · NCI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI BALCH, WILLIAM E · 1993 to 2002
$5.0M
REGULATION OF NEUTROPHIL RECEPTOR/G PROTEIN INTERACTIONSR01GM039434 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI DERMARDIROSSIAN, CELINE · 1988 to 2009
$4.7M
REGULATION OF P21-ACTIVATED KINASESR01GM054168 · NIGMS · INSTITUTE FOR CANCER RESEARCH · PI CHERNOFF, JONATHAN D. · 1997 to 2004
$1.3M
BHP HRSA HHS AHA-9930121NNCI NIH HHS CA-58689NIGMS NIH HHS GM-39434NIGMS NIH HHS R01 GM039434NIGMS NIH HHS R01 GM054168
6 · The paper itself

Abstract

The process of macropinocytosis is an essential aspect of normal cell function, contributing to both growth and motile processes of cells. p21-activated kinases (PAKs) are targets for activated Rac and Cdc42 guanosine 5'-triphosphatases and have been shown to regulate the actin-myosin cytoskeleton. In fibroblasts PAK1 localizes to areas of membrane ruffling, as well as to amiloride-sensitive pinocytic vesicles. Expression of a PAK1 kinase autoinhibitory domain blocked both platelet-derived growth factor- and RacQ61L-stimulated uptake of 70-kDa dextran particles, whereas an inactive version of this domain did not, indicating that PAK kinase activity is required for normal growth factor-induced macropinocytosis. The mechanisms by which PAK modulate macropinocytosis were examined in NIH3T3 cell lines expressing various PAK1 constructs under the control of a tetracycline-responsive transactivator. Cells expressing PAK1 (H83,86L), a mutant that dramatically stimulates formation of dorsal membrane ruffles, exhibited increased macropinocytic uptake of 70-kDa dextran particles in the absence of additional stimulation. This effect was not antagonized by coexpression of dominant-negative Rac1-T17N. In the presence of platelet-derived growth factor, both PAK1 (H83,86L) and a highly kinase active PAK1 (T423E) mutant dramatically enhanced the uptake of 70-kDa dextran. Neither wild-type PAK1 nor vector controls exhibited enhanced macropinocytosis, nor did PAK1 (H83,86L) affect clathrin-dependent endocytic mechanisms. Active versions of PAK1 enhanced both growth factor-stimulated 70-kDa dextran uptake and efflux, suggesting that PAK1 activity modulated pinocytic vesicle cycling. These data indicate that PAK1 plays an important regulatory role in the process of macropinocytosis, perhaps related to the requirement for PAK in directed cell motility.

Indexed as

3T3 CellsAmino Acid SubstitutionAnimalsBecaplerminBiological TransportDextransGenetic VectorsMiceMutagenesis, Site-Directedp21-Activated KinasesPinocytosisPlatelet-Derived Growth FactorProtein Serine-Threonine KinasesProto-Oncogene Proteins c-sisrac1 GTP-Binding ProteinRecombinant ProteinsBecaplerminDextransp21-Activated KinasesPlatelet-Derived Growth FactorProtein Serine-Threonine KinasesProto-Oncogene Proteins c-sisrac1 GTP-Binding ProteinRecombinant ProteinsTrans-Activators

Identifiers

PMID11029040
PMCPMC14996
OpenAlexW2127488207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.